Compile Data Set for Download or QSAR
Report error Found 35 Enz. Inhib. hit(s) with all data for entry = 13214
TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767400BDBM767400(1-[[3-[4-[4-[[2-allyl-3-oxo-1-(2- pyridyl)pyrazolo...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767399BDBM767399(2-[1-[4-[[2-methyl-3-oxo-1-(2- pyridyl)pyrazolo[3,...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767402BDBM767402(4-[[4-fluoro-3-[[4-[4-[[1-[6-(1- hydroxy-1-methyl-...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767401BDBM767401(1-[[3-[[4-[4-[2-allyl-1-[6-(1- hydroxy-1-methyl-et...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767396BDBM767396(2-[4-[[4-[4-[[2-allyl-3-oxo-1-(2- pyridyl)pyrazolo...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767398BDBM767398(1-[[3-[4-[4-[[2-allyl-1-[6-(1-hydroxy- 1-methyl-et...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767397BDBM767397(4-[[4-fluoro-3-[4-[4-[1-[6-(1- hydroxy-1-methyl-et...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767390BDBM767390(4-[[3-[4-[4-[[2-allyl-1-[3-(1-hydroxy- 1-methyl-et...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767416BDBM767416(6-fluoro-2-[4-[[4-[4-[[1-[6-(1- hydroxy-1-methyl-e...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767415BDBM767415(6-fluoro-2-[4-[[4-[4-[[2-methyl-3- oxo-1-(2-pyridy...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767418BDBM767418(4-[[4-fluoro-3-[4-[4-[[1-[6-(1- hydroxy-1-methyl-e...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767408BDBM767408(4-[[4-fluoro-3-[4-[4-[(2-methyl-3- oxo-1-pyrimidin...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767407BDBM767407(2-[4-[[4-[4-[2-allyl-1-[6-(1-hydroxy- 1-methyl-eth...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767420BDBM767420(4-[[4-fluoro-3-[4-[4-[2-(2- methoxyethyl)-3-oxo-1-...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767404BDBM767404(2-[1-[4-[2-methyl-3-oxo-1-(2- pyridyl)pyrazolo[3,4...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767419BDBM767419(4-[[3-[[4-[4-[[2-allyl-1-[6-(1- hydroxy-1-methyl-e...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767403BDBM767403(4-[[3-[4-[4-[[2-allyl-3-oxo-1-(2- pyridyl)pyrazolo...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767406BDBM767406(2-[1-[4-[[2-methyl-3-oxo-1-(2- pyridyl)pyrazolo[3,...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767405BDBM767405(5-fluoro-1-[[4-fluoro-3-[4-[4-[[2- methyl-3-oxo-1-...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767423BDBM767423(2-[1-[4-[1-methyl-3-oxo-2-(2- pyridyl)pyrazolo[3,4...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767422BDBM767422(2-[1-[4-[1-methyl-3-oxo-2-(2- pyridyl)pyrazolo[3,4...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767417BDBM767417(6-fluoro-2-[4-[[4-[4-[[2-(2- methoxyethyl)-3-oxo-1...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767421BDBM767421(4-[[4-fluoro-3-[4-[4-[[2-(2- hydroxyethyl)-3-oxo-1...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767392BDBM767392(4-[[4-fluoro-3-[4-[4-[2-methyl-3- oxo-1-(2-pyridyl...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767410BDBM767410(5-fluoro-1-[[4-fluoro-3-[4-[4-[(2- methyl-3-oxo-1-...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767409BDBM767409(2-fluoro-5-[(5-fluoro-2,4-dioxo- quinazolin-1-yl)m...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767424BDBM767424(2-[1-[4-[1-methyl-3-oxo-2-(2- pyridyl)pyrazolo[3,4...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767412BDBM767412(5-fluoro-1-[[4-fluoro-3-[4-[4-[[1- methyl-3-oxo-2-...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767395BDBM767395(N-[2-[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl)-2-p...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767411BDBM767411(4-[[4-fluoro-3-[4-[4-[[1-methyl-3- oxo-2-(2-pyridy...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767414BDBM767414(2-[4-[[4-[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl)...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767413BDBM767413(2-[4-[[4-[[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767391BDBM767391(4-[[3-[4-[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl)...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767394BDBM767394(4-[[4-fluoro-3-[4-[2-methyl-3-oxo-1- (2-pyridyl)py...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 767393BDBM767393(4-[[3-[4-[[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent